Medical News

RSS

Women from Venus love chocolate from Mars

CocoaVia the long-awaited chocolate from confectionery giant Mars is about to hit the market.

22 Feb 2006

Teens think oral sex is not sex

According to a new national survey almost a quarter of sexually active Canadian teens between the ages of 14 and 17 have unprotected sex and 68 per cent have oral sex, although many are unaware that STIs can be transmitted through this particular sexual activity.

22 Feb 2006

Two drug giants team up to develop new bird flu therapy

Two major drug companies have teamed up in order to develop a treatment for pandemic flu strains.

22 Feb 2006

Rotavirus vaccine given the green light

The Food and Drug Administration in the U.S. has recommended a new vaccine for routine use against rotavirus infection.

22 Feb 2006

Heart health and lifestyle help seniors maintain brain power

A comprehensive review says heart health risk factors and lifestyle choices, such as exercise, learning new things and staying socially connected, help keep brains healthy as we grow old.

22 Feb 2006

Stress in early pregnancy can cause miscarriage

According to a team of researchers in the U.S., women who exhibit signs of stress are three times more likely to miscarry during the first three weeks of the pregnancy.

22 Feb 2006

High alert as bird flu sweeps relentlessly across the globe

The spread of the deadly H5N1 strain of bird flu continues relentlessly across the world with the confirmation that dead swans found in Hungary and Croatia this week also succumbed to the virus.

22 Feb 2006

Concern grows over possible bird flu spread in West Africa

The FAO has expressed growing concern that the bird flu virus H5N1 may spread to other countries in West Africa following the discovery of the virus in Nigeria last week. The effects on a region already facing severe malnutrition would be devastating, the UN agency warned.

21 Feb 2006

Statins and beta blockers may reduce heart attack risk

For patients with undiagnosed heart disease, taking a statin or beta blocker could mean the difference between experiencing mild chest pain, or having a full-blown heart attack as a first symptom. That's the finding of a Kaiser Permanente study in the February 21 issue of the Annals of Internal Medicine.

21 Feb 2006

Mutations in H5N1 avian influenza viruses

Several recent media reports have included speculations about the significance of mutations in H5N1 avian influenza viruses. Some reports have suggested that the likelihood of another pandemic may have increased as a result of changes in the virus.

21 Feb 2006

Extract from Scutellaria Barbata may treat breast cancer

A new clinical formulation extracted from a botanical may provide physicians with a new tool in treating aggressive late-stage breast cancer.

21 Feb 2006

More time exercising not intensity results in long-term weight loss

Women fighting the post-pregnancy weight battle face a lot of challenges, not the least of which is just finding the time to exercise. New research from Duke University suggests that more time exercising -- not intensity -- results in long-term weight loss.

21 Feb 2006

Reovirus may be able to eliminate cancer cells from autologous stem cell transplants

Medical studies show that a common virus may be able to eliminate cancer cells from autologous stem cell transplants.

21 Feb 2006

Ebola DNA vaccine shows promise

Vical Incorporated has announced that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine.

21 Feb 2006

M. D. Anderson Cancer Center to investigate CTCE-9908 chemokine CXCR4 antagonist

Chemokine Therapeutics has announced that it has entered into an agreement with The University of Texas M. D. Anderson Cancer Center of Houston, Texas to study the Company's lead anti-cancer compound, CTCE-9908, a chemokine CXCR4 antagonist.

21 Feb 2006

Multikine treatment increases survival in cancer patients

CEL-SCI Corporation has announced positive results from a long-term follow-up study of head & neck cancer patients treated with its drug Multikine in a Phase II clinical trial.

21 Feb 2006

Pfizer receives FDA approval for Eraxis to treat candidemia

Pfizer said today that Eraxis (anidulafungin) has been approved by the U.S. Food and Drug Administration to treat candidemia, a potentially life-threatening bloodstream infection. Candidemia is the most deadly of the common hospital-acquired bloodstream infections, with a mortality rate of approximately 40 percent.

21 Feb 2006